JAM2 and colorectal carcinoma: Observational studies documented aberrant expression of CAV1, COL1A2, COL3A1, COL5A2, COL6A3, COL11A1, ITGA1, ITGA5, ITGB1, LAMA4, JAM2, JAM3, and VCAM1 in CRC, among others [41,42,43,44,45,46,47,48,49,50,51,52,53].